Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Outlook 2026–2035 Driven by Key Growth Factors and Industry Projections
The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Size Growth Is Projected For The Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market During The Forecast Period 2026–2030?
The artificial intelligence (AI)-powered rare disease diagnosis market size has experienced significant growth in recent years. It is projected to expand from $1.99 billion in 2025 to $2.56 billion in 2026, achieving a compound annual growth rate (CAGR) of 28.9%. This historical growth can be attributed to various factors such as increasing diagnostic complexities for rare conditions, enhanced availability of genetic testing, rising investments in rare disease research, the expanding utilization of data analytics in healthcare, and the early adoption of AI-driven diagnostic tools.
The artificial intelligence (AI)-powered rare disease diagnosis market is set to experience significant expansion over the next few years. It is forecast to attain a valuation of $7.08 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 28.9%. This anticipated growth during the forecast period can be linked to a heightened focus on personalized medicine, the increasing implementation of AI-assisted clinical decision support, the broader integration of genomic sequencing, expanding investment in rare disease screening initiatives, and a rising demand for diagnostic efficiency. Prominent trends observed within this period include the expanding application of AI for pattern recognition in rare diseases, the surging adoption of genomic data analytics platforms, the growing incorporation of multi-modal patient data, the development of cloud-based diagnostic solutions, and an intensified commitment to early and accurate diagnosis.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=28139&type=smp
Which Major Factors Are Driving The Expansion Of The Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market?
The expanding occurrence of autoimmune conditions is projected to fuel the expansion of the artificial intelligence (AI)-powered rare disease diagnosis market moving ahead. Autoimmune disorders are characterized by the immune system erroneously targeting healthy cells and tissues within the body, leading to inflammation and damage. The rise in autoimmune disorders stems from an increasing number of people facing immune system malfunctions, consequently boosting the need for prompt diagnosis, sophisticated treatments, and ongoing surveillance for effective symptom management. Artificial intelligence (AI)-powered rare disease diagnosis aids in the management of autoimmune disorders by swiftly pinpointing intricate conditions, assisting in tailored treatment choices, and enhancing general diagnostic precision. An illustrative example is provided by the Mayo Clinic, a US-based nonprofit academic medical center, which reported in January 2025 that an estimated 15 million individuals suffer from at least one of 105 autoimmune diseases. Consequently, the expanding occurrence of autoimmune conditions acts as a significant catalyst for the growth of the artificial intelligence (AI)-powered rare disease diagnosis market.
What Market Segments Are Evaluated Within The Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market?
The artificial intelligence (AI)-powered rare disease diagnosis market covered in this report is segmented –
1) By Component: Software, Hardware, Services
2) By Technology: Machine Learning, Deep Learning, Natural Language Processing, Computer Vision, Other Technologies
3) By Deployment Mode: Cloud-Based, On-Premises
4) By Diagnosis Type: Genetic Disorders, Autoimmune Disorders, Metabolic Disorders, Infectious Diseases, Other Diagnosis Types
5) By End-User: Hospitals, Diagnostic Centers, Research Institutes, Specialty Clinics, Other End-Users
Subsegments:
1) By Software: Clinical Decision Support, Data Analytics Platforms, Genomic Interpretation Tools, Machine Learning Algorithms, Diagnostic Reporting Software
2) By Hardware: Sequencing Instruments, Imaging Devices, Laboratory Equipment, Computational Servers, Diagnostic Sensors
3) By Services: Consulting Services, Implementation And Integration, Training And Support, Data Management Services, Maintenance And Upgrades
How Are Trends Shaping The Direction Of The Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market?
Major companies operating in the artificial intelligence (AI)-powered rare disease diagnosis market are concentrating on developing innovative technologies, such as unified genomic diagnostics solutions, to enhance diagnostic accuracy, reduce turnaround time, and provide more comprehensive insights into complex genetic disorders. A unified genomic diagnostics solution is an integrated system that combines whole-genome sequencing with artificial intelligence (AI)-driven analysis to deliver complete genetic insights. For instance, in October 2023, Oxford Nanopore Technologies plc, a UK-based biotechnology company, and Fabric Genomics Inc., a US-based artificial intelligence (AI)-based company, launched an integrated whole-genome sequencing solution aimed at accelerating rare disease diagnosis by merging rapid sequencing with AI-driven variant interpretation for more accurate and actionable clinical insights. This launch integrates real-time nanopore sequencing with artificial intelligence (AI)-powered genomic analysis to rapidly identify rare genetic variants, delivering comprehensive and actionable insights to clinicians, thus enhancing diagnostic speed and accuracy for pediatric care.
Who Are The Top Market Participants Influencing The Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market?
Major companies operating in the artificial intelligence (AI)-powered rare disease diagnosis market are Ambry Genetics Corporation, MedGenome Inc., Sophia Genetics SA, Variantyx Inc., Atropos Health Inc., Congenica Ltd., Saventic Care Sp. z o.o., Rapid Innovation LLC, Centogene N.V., Impilo AB, ThinkGenetic Inc., ClairLabs Ltd., 3billion Inc., OpenEvidence Inc., GenomeUp S.R.L., Mendel.ai Inc., RareSum GmbH, DeepRare AI Solutions, Zebra-Llama Project
Read the full artificial intelligence (ai)-powered rare disease diagnosis market report here:
Which Region Currently Holds The Largest Share Of The Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market?
North America was the largest region in the artificial intelligence (AI)-powered rare disease diagnosis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI)-powered rare disease diagnosis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=28139&type=smp
Browse Through More Reports Similar to the Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market 2026, By The Business Research Company
Artificial Intelligence In The Diagnostic Global Market Report
Ai In Medical Diagnostics Global Market Report
https://www.thebusinessresearchcompany.com/report/ai-in-medical-diagnostics-global-market-report
Artificial Intelligence In Cancer Diagnostics Global Market Report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
